This area of the Britannia website contains Press Releases.

16th April 2013 - AM IMPAKT – New  clinical trial investigates apomorphine injection for resolving debilitating  morning akinesia in Parkinson’s disease more

11th April 2013 -  Britannia Pharmaceuticals launch more

March 2013 - Britannia Pharmaceuticals (part of the STADA  Arzneimittel group of companies) has appointed Robert Wood as Marketing Director, for international more

5th October 2012 - Experts at EFNS 2012 symposium believe earlier initiation of continuous dopaminergic stimulation (CDS) therapy is beneficial in advanced Parkinson's disease (PD) more

25th June 2012 - Webinar with EURO-INF Project Leader Professor K Ray Chaudhuri discloses significant benefits of apomorphine and intrajejunal levodopa infusion in advanced Parkinson's more

11th May 2012 - APO-go: simplifying the challenge of Parkinson's therapy in advanced more